Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Edgewise Therapeutics has the lowest figure of the 115 health care companies ranked by P/E ratio, at 4.9, followed by Alnylam Pharmaceuticals (7.5) and Universal Health Services (7.8). Figures as of 19 Nov 2026, 06:35 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- Lowest
- Edgewise Therapeutics4.9
- Median
- 30.7
- Combined market value
- SAR 34.12T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewise TherapeuticsEWTX · Health Care | 4.9 | SAR 17B | SAR 155.18 | 1.59% down | 88% up | ||
| 2 | Alnylam PharmaceuticalsALNY · Health Care | 7.5 | SAR 75.1B | SAR 560.40 | 4.54% down | 66% down | ||
| 3 | Universal Health ServicesUHS · Health Care | 7.8 | SAR 40.2B | SAR 697.95 | 3.08% down | 16% down | ||
| 4 | Tenet HealthcareTHC · Health Care | 7.9 | SAR 81B | SAR 1,017.80 | 3.80% down | 45% up | ||
| 5 | CVS HealthCVS · Health Care | 9.4 | SAR 390.4B | SAR 305.14 | 5.20% down | 12% up | ||
| 6 | Bio-Rad LaboratoriesBIO · Health Care | 9.8 | SAR 37.3B | SAR 1,388.51 | 3.34% up | 18% up | ||
| 7 | Novo NordiskNVO · Health Care | 10.0 | SAR 651.9B | SAR 147.90 | 3.12% down | 17% down | ||
| 8 | GrifolsGRFS · Health Care | 10.2 | SAR 21.6B | SAR 31.77 | 1.85% down | 1% up | ||
| 9 | Caris Life SciencesCAI · Health Care | 11.7 | SAR 21B | SAR 73.14 | 2.21% down | 17% down | ||
| 10 | Fresenius Medical CareFMS · Health Care | 12.1 | SAR 40.8B | SAR 78.58 | 3.41% down | 5% down | ||
| 11 | DaVitaDVA · Health Care | 12.2 | SAR 38.2B | SAR 606.87 | 6.48% down | 50% up | ||
| 12 | Oscar HealthOSCR · Health Care | 12.3 | SAR 32.1B | SAR 103.42 | 7.61% down | 112% up | ||
| 13 | Cigna GroupCI · Health Care | 12.6 | SAR 282.1B | SAR 1,070.42 | 2.96% down | 8% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | 13.2 | SAR 456.7B | SAR 223.41 | 2.92% down | 34% up | ||
| 15 | ZoetisZTS · Health Care | 14.6 | SAR 130.4B | SAR 320.97 | 2.50% up | 29% down | ||
| 16 | HCA HealthcareHCA · Health Care | 15.8 | SAR 373.2B | SAR 1,786.79 | 4.96% down | 4% up | ||
| 17 | GSKGSK · Health Care | 16.9 | SAR 365.3B | SAR 182.22 | 1.34% down | 6% up | ||
| 18 | Elevance HealthELV · Health Care | 17.0 | SAR 324.9B | SAR 1,503.55 | 7.63% down | 37% up | ||
| 19 | Globus MedicalGMED · Health Care | 17.4 | SAR 35B | SAR 264.56 | 0.77% up | 16% down | ||
| 20 | GE HealthCare TechnologiesGEHC · Health Care | 17.7 | SAR 141.9B | SAR 313.81 | 2.22% up | 13% up | ||
| 21 | Ascendis PharmaASND · Health Care | 17.8 | SAR 66.5B | SAR 1,014.01 | 0.32% down | 28% up | ||
| 22 | Boston ScientificBSX · Health Care | 18.4 | SAR 237.3B | SAR 163.69 | 1.42% up | 56% down | ||
| 23 | CencoraCOR · Health Care | 19.4 | SAR 249.3B | SAR 1,306.51 | 0.64% down | 3% down | ||
| 24 | UnitedHealth GroupUNH · Health Care | 20.0 | SAR 1.18T | SAR 1,312.51 | 10.21% down | 26% up | ||
| 25 | ExelixisEXEL · Health Care | 20.4 | SAR 62.5B | SAR 256.16 | 0.31% down | 63% up | ||
| 26 | Smith & NephewSNN · Health Care | 20.6 | SAR 47.6B | SAR 113.73 | 0.62% down | 5% down | ||
| 27 | Cooper CompaniesCOO · Health Care | 20.9 | SAR 43.3B | SAR 227.87 | 0.05% up | 16% down | ||
| 28 | Regeneron PharmaceuticalsREGN · Health Care | 20.9 | SAR 366.9B | SAR 3,546.68 | 1.28% down | 36% up | ||
| 29 | Encompass HealthEHC · Health Care | 21.6 | SAR 49.7B | SAR 506.12 | 2.14% down | 23% up | ||
| 30 | United TherapeuticsUTHR · Health Care | 21.8 | SAR 92.2B | SAR 2,165.60 | 1.16% down | 23% up | ||
| 31 | ResMedRMD · Health Care | 22.1 | SAR 128B | SAR 910.03 | 2.00% up | 3% down | ||
| 32 | MSA SafetyMSA · Health Care | 22.8 | SAR 25.6B | SAR 665.61 | 2.67% up | 11% up | ||
| 33 | InsuletPODD · Health Care | 22.9 | SAR 36.4B | SAR 525.06 | 3.69% down | 58% down | ||
| 34 | Option Care HealthOPCH · Health Care | 23.0 | SAR 17.8B | SAR 118.94 | 0.25% up | 14% up | ||
| 35 | CenteneCNC · Health Care | 23.2 | SAR 125.3B | SAR 253.00 | 7.03% down | 102% up | ||
| 36 | SanofiSNY · Health Care | 23.4 | SAR 424.4B | SAR 176.75 | 0.86% down | 4% down | ||
| 37 | Henry ScheinHSIC · Health Care | 23.5 | SAR 35.5B | SAR 321.42 | 3.32% up | 17% up | ||
| 38 | Align TechnologyALGN · Health Care | 23.9 | SAR 43.4B | SAR 615.01 | 0.31% up | 22% up | ||
| 39 | Halozyme TherapeuticsHALO · Health Care | 23.9 | SAR 41B | SAR 359.35 | 0.18% down | 37% up | ||
| 40 | Neurocrine BiosciencesNBIX · Health Care | 24.2 | SAR 61.8B | SAR 610.89 | 1.84% down | 20% up | ||
| 41 | MedtronicMDT · Health Care | 24.7 | SAR 483.3B | SAR 377.80 | 1.56% down | 2% up | ||
| 42 | Concentra Group Holdings ParentCON · Health Care | 24.8 | SAR 19.8B | SAR 157.47 | 0.94% down | 120% up | ||
| 43 | AstraZenecaAZN · Health Care | 25.3 | SAR 1.04T | SAR 670.53 | 1.93% down | 2% up | ||
| 44 | Lantheus HoldingsLNTH · Health Care | 25.4 | SAR 25B | SAR 382.60 | 0.20% up | 93% up | ||
| 45 | AmgenAMGN · Health Care | 25.7 | SAR 900.6B | SAR 1,665.03 | 3.07% down | 34% up | ||
| 46 | Quest DiagnosticsDGX · Health Care | 25.9 | SAR 107.2B | SAR 974.10 | 1.30% up | 38% up | ||
| 47 | Koninklijke PhilipsPHG · Health Care | 25.9 | SAR 109.3B | SAR 111.82 | 0.27% down | 10% up | ||
| 48 | Zimmer Biomet HoldingsZBH · Health Care | 26.1 | SAR 73.3B | SAR 387.55 | 1.20% up | 14% up | ||
| 49 | ChemedCHE · Health Care | 26.2 | SAR 26.6B | SAR 2,050.75 | 0.01% down | 27% up | ||
| 50 | PACS GroupPACS · Health Care | 26.3 | SAR 27.6B | SAR 173.67 | 4.63% down | 188% up | ||
| 51 | QiagenQGEN · Health Care | 26.8 | SAR 38.4B | SAR 185.90 | 0.38% down | 12% up | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | 26.9 | SAR 31.1B | SAR 476.98 | 2.00% up | 46% up | ||
| 53 | LivaNovaLIVN · Health Care | 27.1 | SAR 19.5B | SAR 354.62 | 2.85% up | 71% up | ||
| 54 | Ensign GroupENSG · Health Care | 27.2 | SAR 40B | SAR 686.36 | 1.63% down | 4% up | ||
| 55 | McKessonMCK · Health Care | 28.0 | SAR 469.6B | SAR 4,067.70 | 0.66% down | 28% up | ||
| 56 | NovartisNVS · Health Care | 29.6 | SAR 1.1T | SAR 582.19 | 2.46% down | 25% up | ||
| 57 | Labcorp HoldingsLH · Health Care | 30.4 | SAR 112.9B | SAR 1,390.80 | 0.69% up | 41% up | ||
| 58 | AvantorAVTR · Health Care | 30.7 | SAR 39.1B | SAR 57.65 | 1.25% up | 38% up | ||
| 59 | STERISSTE · Health Care | 30.8 | SAR 94.5B | SAR 973.65 | 0.84% up | 1% up | ||
| 60 | IQVIA HoldingsIQV · Health Care | 31.4 | SAR 159.4B | SAR 967.16 | 0.09% up | 18% up | ||
| 61 | Merit Medical SystemsMMSI · Health Care | 32.2 | SAR 19.3B | SAR 322.32 | 1.70% up | 1% up | ||
| 62 | DexComDXCM · Health Care | 32.5 | SAR 115.4B | SAR 309.53 | 0.59% up | 37% up | ||
| 63 | argenxARGX · Health Care | 32.6 | SAR 222B | SAR 3,530.63 | 0.66% down | 4% up | ||
| 64 | StrykerSYK · Health Care | 33.9 | SAR 454.3B | SAR 1,193.38 | 0.19% up | 13% down | ||
| 65 | Vertex PharmaceuticalsVRTX · Health Care | 34.5 | SAR 510.2B | SAR 2,012.22 | 0.42% up | 27% up | ||
| 66 | Agilent TechnologiesA · Health Care | 35.0 | SAR 187.6B | SAR 665.16 | 2.97% up | 19% up | ||
| 67 | HealthEquityHQY · Health Care | 35.1 | SAR 30.2B | SAR 365.01 | 4.45% down | 2% down | ||
| 68 | Medpace HoldingsMEDP · Health Care | 35.9 | SAR 67.9B | SAR 2,426.41 | 0.95% down | 10% up | ||
| 69 | Cardinal HealthCAH · Health Care | 36.0 | SAR 241.3B | SAR 1,043.98 | 0.33% down | 35% up | ||
| 70 | IlluminaILMN · Health Care | 36.1 | SAR 119.1B | SAR 787.75 | 3.65% up | 69% up | ||
| 71 | Thermo Fisher ScientificTMO · Health Care | 36.5 | SAR 962.8B | SAR 2,598.47 | 0.87% up | 20% up | ||
| 72 | HumanaHUM · Health Care | 37.6 | SAR 173.8B | SAR 1,447.06 | 12.98% down | 94% up | ||
| 73 | Mettler-Toledo InternationalMTD · Health Care | 37.7 | SAR 129.6B | SAR 6,516.46 | 1.42% up | 22% up | ||
| 74 | DanaherDHR · Health Care | 37.8 | SAR 603.2B | SAR 857.40 | 1.24% up | 2% up | ||
| 75 | Abbott LaboratoriesABT · Health Care | 39.0 | SAR 678.8B | SAR 391.90 | 0.22% down | 17% down | ||
| 76 | PfizerPFE · Health Care | 40.1 | SAR 599.9B | SAR 105.25 | 1.44% down | 14% up | ||
| 77 | Johnson & JohnsonJNJ · Health Care | 41.4 | SAR 2.46T | SAR 1,022.90 | 2.15% down | 38% up | ||
| 78 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.6 | SAR 46.8B | SAR 56.19 | 1.28% up | 5% up | ||
| 79 | Becton, DickinsonBDX · Health Care | 42.7 | SAR 220.8B | SAR 810.52 | 0.31% up | 43% up | ||
| 80 | Krystal BiotechKRYS · Health Care | 42.8 | SAR 35.1B | SAR 1,182.84 | 5.62% up | 46% up | ||
| 81 | GenmabGMAB · Health Care | 43.6 | SAR 117.9B | SAR 191.19 | 1.91% down | 70% up | ||
| 82 | Eli LillyLLY · Health Care | 44.9 | SAR 4.62T | SAR 5,186.70 | 2.32% down | 35% up | ||
| 83 | Royalty PharmaRPRX · Health Care | 44.9 | SAR 148.1B | SAR 257.58 | 0.01% down | 78% up | ||
| 84 | West Pharmaceutical ServicesWST · Health Care | 45.3 | SAR 105.6B | SAR 1,515.48 | 2.44% down | 61% up | ||
| 85 | IDEXX LaboratoriesIDXX · Health Care | 47.1 | SAR 206.4B | SAR 2,619.96 | 1.19% up | 1% down | ||
| 86 | BrightSpring Health ServicesBTSG · Health Care | 48.5 | SAR 51B | SAR 256.34 | 2.13% down | 116% up | ||
| 87 | AbbVieABBV · Health Care | 49.1 | SAR 1.9T | SAR 1,072.82 | 2.33% down | 26% up | ||
| 88 | Intuitive SurgicalISRG · Health Care | 50.9 | SAR 547.3B | SAR 1,578.98 | 2.23% down | 24% down | ||
| 89 | Corcept TherapeuticsCORT · Health Care | 51.0 | SAR 27.8B | SAR 254.28 | 3.25% down | 8% down | ||
| 90 | BeOne MedicinesONC · Health Care | 51.7 | SAR 172.9B | SAR 1,513.90 | 2.34% down | 17% up | ||
| 91 | HaemoneticsHAE · Health Care | 54.4 | SAR 21B | SAR 460.85 | 1.60% up | 61% up | ||
| 92 | Amneal PharmaceuticalsAMRX · Health Care | 54.7 | SAR 28.6B | SAR 82.07 | 3.60% up | 83% up | ||
| 93 | AlconALC · Health Care | 54.9 | SAR 135.6B | SAR 282.30 | 1.55% up | 2% down | ||
| 94 | IncyteINCY · Health Care | 60.1 | SAR 90.1B | SAR 441.87 | 1.08% down | 18% up | ||
| 95 | Edwards LifesciencesEW · Health Care | 61.2 | SAR 227B | SAR 394.72 | 0.19% down | 23% up | ||
| 96 | Bio-TechneTECH · Health Care | 66.7 | SAR 42.9B | SAR 272.89 | 0.17% up | 26% up | ||
| 97 | RevvityRVTY · Health Care | 67.7 | SAR 63.8B | SAR 571.76 | 3.14% up | 60% up | ||
| 98 | HeartflowHTFL · Health Care | 68.5 | SAR 15.1B | SAR 172.13 | 2.51% down | 73% up | ||
| 99 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 72.0 | SAR 28B | SAR 356.53 | 0.06% down | 126% up | ||
| 100 | Jazz PharmaceuticalsJAZZ · Health Care | 73.3 | SAR 59.7B | SAR 929.39 | 2.93% up | 37% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/E ratio?
Edgewise Therapeutics (4.9), Alnylam Pharmaceuticals (7.5) and Universal Health Services (7.8) have the lowest P/E ratio of the 115 health care companies ranked here as of 19 Nov 2026, 06:35 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of SAR 34.12T as of 19 Nov 2026, 06:35 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.